Literature DB >> 21126569

A systematic genetic polymorphism analysis of the CYP2C9 gene in four different geographical Han populations in mainland China.

Yuyu Xiong1, Ming Wang, Ke Fang, Qinghe Xing, Guoyin Feng, Lu Shen, Lin He, Shengying Qin.   

Abstract

While many studies have been focused on CYP2C9*2 and *3 there was a lack of large full gene sequencing on CYP2C9, and this study was designed to fill this gap. We used direct sequencing to systematically screen genetic polymorphisms of the CYP2C9 gene including the 5' -flanking region (2kb), all exons and their adjoining intron regions and the 3' UTR in 400 unrelated healthy Chinese Han volunteers. A total of 27 different CYP2C9 polymorphisms were identified, 3 of which were novel, including one in intron 6, a synonymous variant (1137T>C, Tyr379Tyr), and a deletion mutation in the 3'UTR (1739-1740ATdel), which potentially influences the stability of CYP2C9 mRNA. We identified CYP2C9*1, *2, *3, *8, *11, and *31, of which alleles *8 was identified for the first time in Chinese population while *11 first in Asian. This is the first systematic screening of genetic polymorphisms of CYP2C9 in the Chinese Han population.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21126569     DOI: 10.1016/j.ygeno.2010.11.004

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  8 in total

1.  In vitro functional characterization of 37 CYP2C9 allelic isoforms found in Chinese Han population.

Authors:  Da-peng Dai; Yu-han Wang; Shuang-hu Wang; Pei-wu Geng; Li-ming Hu; Guo-xin Hu; Jian-ping Cai
Journal:  Acta Pharmacol Sin       Date:  2013-09-30       Impact factor: 6.150

Review 2.  Pharmacogenetics of tamoxifen therapy in Asian populations: from genetic polymorphism to clinical outcomes.

Authors:  Tingyu Wang; Yitian Zhou; Guosheng Cao
Journal:  Eur J Clin Pharmacol       Date:  2021-01-29       Impact factor: 2.953

3.  Meta-analysis of cytochrome P-450 2C9 polymorphism and colorectal cancer risk.

Authors:  Shuo Liang; Jinsong Hu; Jingsong Hu; Weijun Cao; Sanjun Cai
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

Review 4.  Interpretation of mRNA splicing mutations in genetic disease: review of the literature and guidelines for information-theoretical analysis.

Authors:  Natasha Caminsky; Eliseos J Mucaki; Peter K Rogan
Journal:  F1000Res       Date:  2014-11-18

5.  African Genetic Diversity: Implications for Cytochrome P450-mediated Drug Metabolism and Drug Development.

Authors:  Iris Rajman; Laura Knapp; Thomas Morgan; Collen Masimirembwa
Journal:  EBioMedicine       Date:  2017-02-20       Impact factor: 8.143

6.  A systematically combined genotype and functional combination analysis of CYP2E1, CYP2D6, CYP2C9, CYP2C19 in different geographic areas of mainland China--a basis for personalized therapy.

Authors:  Zhenqiang Wu; Xiaoqing Zhang; Lu Shen; Yuyu Xiong; Xi Wu; Ran Huo; Zhiyun Wei; Lei Cai; Guoyang Qi; Qingqing Xu; Daxiang Cui; Donghong Cui; Gengchun Zhao; Lin He; Shengying Qin
Journal:  PLoS One       Date:  2013-10-02       Impact factor: 3.240

7.  In Silico Investigation of Cytochrome P450 2C9 in relation to Aging Using Traditional Chinese Medicine.

Authors:  Tzu-Chieh Hung; Chia-Chen Kuo; Calvin Yu-Chian Chen
Journal:  Evid Based Complement Alternat Med       Date:  2014-05-08       Impact factor: 2.629

8.  Functional Characterization of Human CYP2C9 Allelic Variants in COS-7 Cells.

Authors:  Huihui Du; Zhiyun Wei; Yucai Yan; Yuyu Xiong; Xiaoqing Zhang; Lu Shen; Yunfeng Ruan; Xi Wu; Qingqing Xu; Lin He; Shengying Qin
Journal:  Front Pharmacol       Date:  2016-04-25       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.